1/12
08:34 am
hims
Hims & Hers Health (NYSE:HIMS) is now covered by analysts at Evercore ISI. They set an "in-line" rating and a $33.00 price target on the stock.
Low
Report
Hims & Hers Health (NYSE:HIMS) is now covered by analysts at Evercore ISI. They set an "in-line" rating and a $33.00 price target on the stock.
1/12
08:34 am
hims
Hims & Hers Health (NYSE:HIMS) is now covered by analysts at Evercore ISI. They set an "in-line" rating and a $33.00 price target on the stock.
Low
Report
Hims & Hers Health (NYSE:HIMS) is now covered by analysts at Evercore ISI. They set an "in-line" rating and a $33.00 price target on the stock.
1/12
08:32 am
hims
Rating for HIMS
Medium
Report
Rating for HIMS
1/12
06:19 am
hims
Hims & Hers initiated with an In Line at Evercore ISI
Medium
Report
Hims & Hers initiated with an In Line at Evercore ISI
1/12
06:19 am
hims
Hims & Hers initiated with an In Line at Evercore ISI
Medium
Report
Hims & Hers initiated with an In Line at Evercore ISI
1/5
10:16 am
hims
Hims & Hers Health (NYSE:HIMS) had its "sell" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Hims & Hers Health (NYSE:HIMS) had its "sell" rating reaffirmed by analysts at Citigroup Inc..
12/10
07:18 am
hims
Hims & Hers Health (NYSE:HIMS) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
Medium
Report
Hims & Hers Health (NYSE:HIMS) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
12/9
09:48 am
hims
Rating for HIMS
Low
Report
Rating for HIMS
12/9
09:48 am
hims
Rating for HIMS
Low
Report
Rating for HIMS
12/8
05:04 pm
hims
Hims & Hers Health (NYSE:HIMS) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.
Low
Report
Hims & Hers Health (NYSE:HIMS) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.
12/8
04:05 pm
hims
Hims & Hers initiated with an Overweight at Barclays
Low
Report
Hims & Hers initiated with an Overweight at Barclays
12/8
04:05 pm
hims
Hims & Hers initiated with an Overweight at Barclays
Low
Report
Hims & Hers initiated with an Overweight at Barclays
11/4
08:09 am
hims
Hims & Hers Health (NYSE:HIMS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $85.00 price target on the stock.
Medium
Report
Hims & Hers Health (NYSE:HIMS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $85.00 price target on the stock.
11/4
04:13 am
hims
Rating for HIMS
Medium
Report
Rating for HIMS